Key facts
- CancerCompanion aims to provide emotional support to cancer patients between appointments.
- The Hong Kong University of Science and Technology developed four AI models for cancer diagnosis and care.
- The AI Virtual Patient Simulation System from The Hong Kong Polytechnic University creates a digital twin for personalized treatment.
- AI tools are expected to reduce inefficiencies in medtech companies and physician burnout.
Cancer patients in Hong Kong face persistent emotional distress, which studies link to lower survival chances. Claudia Chan Shu-ying, a medical student at the Chinese University of Hong Kong, is developing CancerCompanion, an AI-powered digital tool to offer emotional support between appointments. This initiative aligns with broader advancements in healthcare AI in Hong Kong. The Hong Kong University of Science and Technology has unveiled four AI models designed to assist in diagnosing and treating over 30 types of cancers and diseases. These include MOME for breast cancer diagnosis, the mSTAR Pathology Assistant Tool, MedDr for medical report generation and initial diagnoses, and XAIM for explaining AI decisions. Separately, The Hong Kong Polytechnic University has created an AI Virtual Patient Simulation System that uses a digital twin approach to integrate multimodal patient data for personalized treatment prediction.